JP2023527083A5 - - Google Patents
Info
- Publication number
- JP2023527083A5 JP2023527083A5 JP2022573287A JP2022573287A JP2023527083A5 JP 2023527083 A5 JP2023527083 A5 JP 2023527083A5 JP 2022573287 A JP2022573287 A JP 2022573287A JP 2022573287 A JP2022573287 A JP 2022573287A JP 2023527083 A5 JP2023527083 A5 JP 2023527083A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032362P | 2020-05-29 | 2020-05-29 | |
| US63/032,362 | 2020-05-29 | ||
| US202163173155P | 2021-04-09 | 2021-04-09 | |
| US63/173,155 | 2021-04-09 | ||
| US202163175842P | 2021-04-16 | 2021-04-16 | |
| US63/175,842 | 2021-04-16 | ||
| PCT/EP2021/062728 WO2021239471A1 (en) | 2020-05-29 | 2021-05-12 | Cancer treatment strategies using arenavirus vectors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527083A JP2023527083A (ja) | 2023-06-26 |
| JPWO2021239471A5 JPWO2021239471A5 (https=) | 2024-06-19 |
| JP2023527083A5 true JP2023527083A5 (https=) | 2024-06-19 |
Family
ID=75914543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573287A Pending JP2023527083A (ja) | 2020-05-29 | 2021-05-12 | アレナウイルスベクターを使用するがんの治療方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230346906A1 (https=) |
| EP (1) | EP4157342A1 (https=) |
| JP (1) | JP2023527083A (https=) |
| KR (1) | KR20230046278A (https=) |
| AU (1) | AU2021282287A1 (https=) |
| BR (1) | BR112022024404A2 (https=) |
| CA (1) | CA3184791A1 (https=) |
| CR (1) | CR20220602A (https=) |
| IL (1) | IL298420A (https=) |
| MX (1) | MX2022014725A (https=) |
| PE (1) | PE20240647A1 (https=) |
| WO (1) | WO2021239471A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2604695B1 (en) | 2007-12-27 | 2022-11-16 | Universität Zürich | Replication-defective arenavirus vectors |
| CN115058452A (zh) | 2013-12-03 | 2022-09-16 | 霍欧奇帕生物科技有限公司 | Cmv疫苗 |
| EP3307308A2 (en) | 2015-06-10 | 2018-04-18 | Hookipa Biotech AG | Hpv vaccines |
| WO2023152116A1 (en) * | 2022-02-08 | 2023-08-17 | Hookipa Biotech Gmbh | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines |
| AU2024343172A1 (en) | 2023-09-15 | 2026-03-05 | Gilead Sciences, Inc. | Arenavirus formulations, methods and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3218504T (lt) | 2014-11-13 | 2020-09-10 | Université De Geneve | Trijų segmentų arenavirusai kaip vakcinos vektoriai |
| EP3307308A2 (en) * | 2015-06-10 | 2018-04-18 | Hookipa Biotech AG | Hpv vaccines |
| RS63546B1 (sr) | 2015-11-12 | 2022-09-30 | Hookipa Biotech Gmbh | Čestice arenavirusa kao vakcine protiv kancera |
| US20190135875A1 (en) | 2016-05-18 | 2019-05-09 | Hookipa Biotech Gmbh | Tri-segmented pichinde viruses as vaccine vectors |
| AU2018247958A1 (en) * | 2017-04-07 | 2019-10-10 | Hookipa Biotech Gmbh | Arenavirus particles to treat solid tumors |
-
2021
- 2021-05-12 MX MX2022014725A patent/MX2022014725A/es unknown
- 2021-05-12 JP JP2022573287A patent/JP2023527083A/ja active Pending
- 2021-05-12 KR KR1020227044315A patent/KR20230046278A/ko active Pending
- 2021-05-12 BR BR112022024404A patent/BR112022024404A2/pt unknown
- 2021-05-12 AU AU2021282287A patent/AU2021282287A1/en active Pending
- 2021-05-12 PE PE2022002786A patent/PE20240647A1/es unknown
- 2021-05-12 US US17/928,098 patent/US20230346906A1/en active Pending
- 2021-05-12 WO PCT/EP2021/062728 patent/WO2021239471A1/en not_active Ceased
- 2021-05-12 EP EP21725519.9A patent/EP4157342A1/en active Pending
- 2021-05-12 IL IL298420A patent/IL298420A/en unknown
- 2021-05-12 CR CR20220602A patent/CR20220602A/es unknown
- 2021-05-12 CA CA3184791A patent/CA3184791A1/en active Pending